Free Trial

HTG Molecular Diagnostics (HTGMQ) Competitors

$0.0003 0.00 (0.00%)
(As of 02:51 PM ET)

HTGMQ vs. CHEK, NSTG, PRPO, IDXG, PMD, A, MTD, WAT, ILMN, and AVTR

Should you be buying HTG Molecular Diagnostics stock or one of its competitors? The main competitors of HTG Molecular Diagnostics include Check-Cap (CHEK), NanoString Technologies (NSTG), Precipio (PRPO), Interpace Biosciences (IDXG), Psychemedics (PMD), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), and Avantor (AVTR).

HTG Molecular Diagnostics vs.

Check-Cap (NASDAQ:CHEK) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.

Check-Cap received 370 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users.

CompanyUnderperformOutperform
Check-CapOutperform Votes
370
63.14%
Underperform Votes
216
36.86%
HTG Molecular DiagnosticsN/AN/A

Company Net Margins Return on Equity Return on Assets
Check-CapN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, Check-Cap had 1 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for HTG Molecular Diagnostics. Check-Cap's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Check-Cap Neutral
HTG Molecular Diagnostics Neutral

Check-Cap has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Comparatively, HTG Molecular Diagnostics has a beta of 2.63, meaning that its share price is 163% more volatile than the S&P 500.

Check-Cap has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Check-CapN/AN/A-$17.57M-$3.00-0.27
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

1.1% of Check-Cap shares are held by institutional investors. 0.5% of Check-Cap shares are held by company insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Check-Cap beats HTG Molecular Diagnostics on 4 of the 7 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTGMQ vs. The Competition

MetricHTG Molecular DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1,000.00$5.36B$5.10B$8.84B
Dividend YieldN/A0.47%5.04%4.07%
P/E RatioN/A8.0195.6214.26
Price / Sales0.004.011,217.1987.73
Price / CashN/A41.0639.5936.27
Price / Book0.002.466.946.36
Net Income-$21.59M$515,312.50$118.89M$225.56M
7 Day PerformanceN/A-4.37%-1.33%-0.10%
1 Month PerformanceN/A-6.94%-3.17%2.02%
1 Year PerformanceN/A-16.09%32.49%27.87%

HTG Molecular Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HTGMQ
HTG Molecular Diagnostics
N/A$0.00
flat
N/A-76.9%$1,000.00$6.37M0.0053High Trading Volume
CHEK
Check-Cap
0.5192 of 5 stars
$0.80
+5.0%
N/A-76.9%$4.68MN/A-0.2780Upcoming Earnings
News Coverage
Gap Up
NSTG
NanoString Technologies
0.3571 of 5 stars
N/AN/AN/A$5.07M$127.26M-0.03550Analyst Forecast
Gap Down
PRPO
Precipio
1.2245 of 5 stars
$6.00
flat
N/A-15.8%$8.88M$15.20M0.0060Positive News
IDXG
Interpace Biosciences
N/A$2.68
+0.4%
N/A+135.6%$11.79M$40.21M0.00152Gap Down
PMD
Psychemedics
0.7025 of 5 stars
$2.34
flat
N/A+11.0%$13.78M$22.10M-4.57140
A
Agilent Technologies
3.9673 of 5 stars
$131.80
+2.5%
$144.36
+9.5%
+12.8%$37.87B$6.83B27.3218,100Upcoming Earnings
News Coverage
MTD
Mettler-Toledo International
4.1646 of 5 stars
$1,191.32
+2.1%
$1,338.75
+12.4%
+11.1%$25.14B$3.79B31.4617,300Positive News
WAT
Waters
4.1559 of 5 stars
$366.45
+2.4%
$365.85
-0.2%
+37.0%$21.76B$2.96B34.137,900
ILMN
Illumina
4.5888 of 5 stars
$136.00
+3.3%
$164.00
+20.6%
+34.9%$21.57B$4.50B0.009,300Positive News
AVTR
Avantor
4.9775 of 5 stars
$20.41
+1.3%
$27.57
+35.1%
+3.6%$13.89B$6.97B43.7814,500Analyst Revision

Related Companies and Tools


This page (NASDAQ:HTGMQ) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners